Page 5 - Throughput Screening News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Human Microbiome Market worth $1,598 million by 2028 - Exclusive Report by MarketsandMarkets "Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics) - Global Forecast to 2028", published by MarketsandMarkets, the global Human Microbiome Market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025, at a CAGR of 21.3% from 2025 to 2028. Browse in-depth TOC on Download PDF Brochure: https://www.mar...

/PRNewswire/ -- According to the new market research report "Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs),...

High-Throughput Screening Market worth $26.4 billion by 2025 - Exclusive Report by MarketsandMarkets "High-Throughput Screening (HTS) Market by Product (Instruments, Software, Service), Technology (Cell-Based Assays, Label-Free), Application (Drug Discovery, Biochemical Screening, Research), End User (Pharma & Biotech, CROs)- Global Forecast to 2025", published by MarketsandMarkets, the global High-Throughput Screening Market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5% during the forecast period. Browse in-depth TOC on Download PDF...

The HTS Market growth is driven mainly by factors such as increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets and growing applications in life sciences research are also factors expected to provide growth opportunities for players in the market. The consumables segment accounted for the largest share of the product & services segment in the high-throughput screening market in 2019. On the basis type of product & service, the...

Product News: TR-FRET readout now available with the Transcreener cGAMP cGAS Assay With this addition, researchers can more easily screen for small molecule modulators of cGAS 26 Jan 2021 Launched in November 2019, the Transcreener cGAMP cGAS Assay has generated a great deal of interest in the drug discovery community. While fluorescence polarization (FP) readouts offer a stable and robust option, some researchers prefer time-resolved Förster-resonance-energy-transfer (TR-FRET) readouts for large screens. After months of development, BellBrook Labs is pleased to announce the addition of a TR...